Company intelligence / Profile preview

BioWave

Norwalk, Connecticut, United Statesbiowave.com ↗

Ownership: Private
Employees: ~72
Development stage: Other

Overview

BioWave’s FDA-cleared, patented high-frequency neurostimulation technology is clinically proven to provide significant reduction in acute and chronic pain. Clinical studies and patient surveys report improved quality of life, increased function, and long-lasting relief after short treatment sessions. The technology is widely adopted by professional athletes, the Veterans Administration, and healthcare providers nationwide.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

Veterans Administration (VA)Department of Labor & Active Military health systemsOver 120 professional sports teams across NFL/NBA/NHL/MLBMore than 160 NCAA programs

Beyond the preview

Go deeper on BioWave.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioWave.

Explore the full profile